(Q53232817)

12 May 2018

title

Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids. (English)

1 reference

12 May 2018

author name string

Jolivalt C

1

1 reference

12 May 2018

Leininger-Muller B

2

1 reference

12 May 2018

Bertrand P

3

1 reference

12 May 2018

Herber R

4

1 reference

12 May 2018

Christen Y

5

1 reference

12 May 2018

Siest G

6

1 reference

12 May 2018

publication date

1 January 2000

1 reference

12 May 2018

Free Radical Biology and Medicine

published in

1 reference

12 May 2018

volume

28

1 reference

12 May 2018

issue

1

1 reference

12 May 2018

page(s)

129-140

1 reference

12 May 2018

Reactive oxygen species and the central nervous system

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Protein oxidation in aging, disease, and oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Role of protein oxidation in aging and in age-associated neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Frequency of the apolipoprotein E epsilon 2 allele is diminished in sporadic Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Apolipoprotein E: structure-function relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Apolipoprotein E carboxyl-terminal fragments are complexed to amyloids A and L. Implications for amyloidogenesis and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Crosslinking of apolipoprotein E by products of lipid peroxidation.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Apolipoprotein oxidation in the absence of lipid peroxidation enhances LDL uptake by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Effects of ebselen and probucol on oxidative modifications of lipid and protein of low density lipoprotein induced by free radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Occurrence of oxidatively modified proteins: an early event in experimental acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Human low density lipoprotein as a target of hypochlorite generated by myeloperoxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Inflammation-associated amyloidogenesis. Lessons for Alzheimer's amyloidogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Apolipoprotein E is highly susceptible to oxidation by myeloperoxidase, an enzyme present in the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Rapid and efficient purification of native histidine-tagged protein expressed by recombinant vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Large-scale isolation and purification of human apolipoproteins A-I and A-II

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Chloramines as intermediates of oxidation reaction of amino acids by myeloperoxidase.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Immunochemical detection of oxidized proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

A review of plasma apolipoprotein A-I interactions with phosphatidylcholines

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Protein oxidation and amino acid-DNA crosslinking by nickel compounds in intact cultured cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Apolipoprotein E polymorphism and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Methionine residues as endogenous antioxidants in proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Novel mechanism for defective receptor binding of apolipoprotein E2 in type III hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Functions of glutathione and glutathione disulfide in immunology and immunopathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Inefficient degradation of oxidized regions of protein molecules.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Choline metabolism as a basis for the selective vulnerability of cholinergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Neurodegeneration in the central nervous system of apoE-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

Oxidative damage and motor neurone disease difficulties in the measurement of protein carbonyls in human brain tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900232-4

7 January 2021

10.1016/S0891-5849(99)00232-4

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018